This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Management of Postoperative Pain After Total Knee Replacement.

Sponsored by Mark J. Spangehl, M.D.

About this trial

Last updated 11 years ago

Study ID

10-003312

Status

Completed

Type

Interventional

Phase

Phase 4

Placebo

No

Accepting

18-75 Years
18 to 79 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 12 years ago

What is this trial about?

The purpose of this study is to compare two methods of postoperative pain management in patients undergoing total knee replacement.

What are the participation requirements?

Yes

Inclusion Criteria

- Unilateral primary total knee replacement.

- Weight 50-125 kg.

- Age 18-79 years.

- Intact neurological exam to the surgical lower extremity.

- Cognitively intact with ability to sign informed consent.

No

Exclusion Criteria

- Renal insufficiency with creatinine >1.5 mg/dL.

- Allergy to medication used in the study.

- Using narcotic medication prior to surgery (morphine equivalents >=20 mg/day for >7 days.)

- Prior open knee surgery with regional anesthesia or periarticular injection for post-operative pain management.

Locations

Location

Status